| Literature DB >> 33040314 |
Tatiana Barichello1,2,3, Vijayasree Vayalanellore Giridharan4, Gursimrat Bhatti4, Pavani Sayana4, Tejaswini Doifode4, Danielle Macedo5,6, Joao Quevedo4,7,8,9.
Abstract
Bipolar disorder (BD) is a severe, debilitating psychiatric condition with onset in adolescence or young adulthood and often follows a relapsing and remitting course throughout life. The concept of neuroprogression in BD refers to the progressive path with an identifiable trajectory that takes place with recurrent mood episodes, which eventually leads to cognitive, functional, and clinical deterioration in the course of BD. Understanding the biological basis of neuroprogression helps to explain the subset of BD patients who experience worsening of their disorder over time. Additionally, the study of the neurobiological mechanisms underpinning neuroprogression will help BD staging based on systems biology. Replicated epidemiological studies have suggested inflammatory mechanisms as primary contributors to the neuroprogression of mood disorders. It is known that dysregulated inflammatory/immune pathways are often associated with BD pathophysiology. Hence, in this chapter, we focus on the evidence for the involvement of inflammation and immune regulated pathways in the neurobiological consequences of BD neuroprogression. Herein we put forth the evidence of immune markers from autoimmune disorders, chronic infections, and gut-brain axis that lead to BD neuroprogression. Further, we highlighted the peripheral and central inflammatory components measured along with BD progression.Entities:
Keywords: Bipolar disorder; Host immune response; Inflammation; Neuroprogression
Mesh:
Substances:
Year: 2021 PMID: 33040314 DOI: 10.1007/7854_2020_173
Source DB: PubMed Journal: Curr Top Behav Neurosci ISSN: 1866-3370